IPG Photonics to acquire Lumibird Medical for €300M plus €50M earn-out

IPG PHOTONICS CORP

Acquiring 100% of Lumibird Medical from Lumibird S.A. for €300M on cash-free, debt-free basis.
Contingent earn-out of up to €50M based on 2026-2027 performance metrics.
Closing expected Q4 2026; subject to French FDI approval and AMF waiver.
Funding from cash on hand; W&I insurance policy secured.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.